Division of Clinical Dentistry, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Division of Clinical Dentistry, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
J Endod. 2018 Jun;44(6):914-922.e2. doi: 10.1016/j.joen.2018.02.017. Epub 2018 Apr 27.
Successful anesthesia with an inferior alveolar nerve block (IANB) is imperative for treating patients with irreversible pulpitis in mandibular teeth. This systematic review assessed the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) as oral premedications on the success of IANBs in irreversible pulpitis.
Three databases were searched to identify randomized clinical trials (RCTs) published up until September 2017. Retrieved RCTs were evaluated using the revised Cochrane Risk of Bias Tool. The primary efficacy outcome of interest was the success rate of IANB anesthesia. Meta-analytic estimates (risk ratio [RR] with 95% confidence intervals [CIs]) performed using a random effects model and publication bias determined using funnel plot analysis were assessed. Random errors were evaluated with trial sequential analyses, and the quality of evidence was appraised using a Grading of Recommendations, Assessment, Development and Evaluation approach.
Thirteen RCTs (N = 1034) were included. Eight studies had low risk of bias. Statistical analysis of good-quality RCTs showed a significant beneficial effect of any NSAID in increasing the anesthetic success of IANBs compared with placebo (RR = 1.92; 95% CI, 1.55-2.38). Subgroup analyses showed a similar beneficial effect for ibuprofen, diclofenac, and ketorolac (RR = 1.83 [95% CI, 1.43-2.35], RR = 2.56 [95% CI, 1.46-4.50], and RR = 2.07 [95% CI, 1.47-2.90], respectively). Dose-dependent ibuprofen >400 mg/d (RR = 1.85; 95% CI, 1.39-2.45) was shown to be effective; however, ibuprofen ≤400 mg/d showed no association (RR = 1.78; 95% CI, 0.90-3.55). TSA confirmed conclusive evidence for a beneficial effect of NSAIDs for IANB premedication. The Grading of Recommendations, Assessment, Development and Evaluation approach did not reveal any concerns regarding the quality of the results.
Oral premedication with NSAIDs and ibuprofen (>400 mg/d) increased the anesthetic success of IANBs in patients with irreversible pulpitis.
对于下颌牙齿不可逆性牙髓炎患者,成功施行下齿槽神经阻滞麻醉(IANB)至关重要。本系统评价评估了非甾体类抗炎药(NSAIDs)作为口腔预给药对 IANB 在不可逆性牙髓炎中成功率的影响。
检索截至 2017 年 9 月发表的随机临床试验(RCT),使用改良 Cochrane 偏倚风险工具评估纳入的 RCT。主要疗效结局为 IANB 麻醉的成功率。采用随机效应模型进行 Meta 分析(风险比 [RR]及其 95%置信区间 [CI]),并采用漏斗图分析评估发表偏倚。采用试验序贯分析评估随机误差,使用推荐评估、制定与评价分级方法评估证据质量。
纳入 13 项 RCT(N=1034)。8 项研究的偏倚风险较低。对高质量 RCT 的统计学分析显示,与安慰剂相比,任何 NSAID 均显著增加 IANB 麻醉的成功率(RR=1.92;95%CI,1.55-2.38)。亚组分析显示,布洛芬、双氯芬酸和酮咯酸也有类似的有益效果(RR=1.83[95%CI,1.43-2.35]、RR=2.56[95%CI,1.46-4.50]和 RR=2.07[95%CI,1.47-2.90])。布洛芬剂量依赖性>400mg/d(RR=1.85;95%CI,1.39-2.45)有效,而布洛芬≤400mg/d 则无相关性(RR=1.78;95%CI,0.90-3.55)。试验序贯分析证实 NSAIDs 对 IANB 预给药有有益作用的结论确凿。推荐评估、制定与评价分级方法并未发现任何与结果质量相关的担忧。
口服 NSAIDs 和布洛芬(>400mg/d)预给药可提高不可逆性牙髓炎患者 IANB 的麻醉成功率。